Bank Julius Baer & Co’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Sell
2,429
-3,282
-57% -$278K ﹤0.01% 515
2026
Q1
$568K Sell
5,711
-52
-0.9% -$6.78K ﹤0.01% 428
2025
Q4
$701K Buy
5,763
+288
+5% +$36.1K ﹤0.01% 398
2025
Q3
$614K Buy
5,475
+23
+0.4% +$2.69K ﹤0.01% 402
2025
Q2
$731K Sell
5,452
-578
-10% -$63.5K ﹤0.01% 353
2025
Q1
$406K Buy
6,030
+627
+12% +$43.1K ﹤0.01% 383
2024
Q4
$372K Buy
5,403
+693
+15% +$64.5K ﹤0.01% 375
2024
Q3
$877K Sell
4,710
-552
-10% -$85.1K ﹤0.01% 296
2024
Q2
$882K Buy
5,262
+483
+10% +$57.9K ﹤0.01% 243
2024
Q1
$353K Buy
+4,779
New +$394K ﹤0.01% 344

Other funds holding TMDX

Bank Julius Baer & Co's TMDX Position: Q2 2026 in Review

Bank Julius Baer & Co reduced its Transmedics (TMDX) stake by 57% in Q2 2026, selling an estimated $278K and leaving 2,429 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Bank Julius Baer & Co first reported a position in TMDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $882K in Q2 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Bank Julius Baer & Co held 2,429 shares of Transmedics worth $162K as of Q2 2026.
  • Bank Julius Baer & Co sold 3,282 Transmedics shares in Q2 2026, an estimated $278K.
  • Transmedics made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #515 holding.
  • Bank Julius Baer & Co first reported a position in Transmedics in Q1 2024 and has held it in 10 quarters since.
  • Bank Julius Baer & Co's Transmedics position peaked at $882K in Q2 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.